Alessandro Parente
Queen Elizabeth Hospital Birmingham
2 Papers
Alessandro Parente is an academic researcher from Queen Elizabeth Hospital Birmingham. The author has contributed to research in topics: Liver transplantation & Percentile. The author has an hindex of 1, co-authored 2 publications.
Chat about Author
Papers
A multicentre outcome analysis to define global benchmarks for donation after circulatory death liver transplantation.
Andrea Schlegel,Andrea Schlegel,Andrea Schlegel,BONG YOO,Marjolein van Reeven,Kristopher P. Croome,Alessandro Parente,Annalisa Dolcet,Jeannette Widmer,Jeannette Widmer,Nicolas Meurisse,Riccardo De Carlis,Amelia J. Hessheimer,Ina Jochmans,Matteo Mueller,Otto B. van Leeuwen,Amit Nair,Amit Nair,Koji Tomiyama,Ahmed Sherif,Mohamed Elsharif,Philipp Kron,Philipp Kron,Danny van der Helm,Daniel Borja-Cacho,Humberto Bohorquez,Desislava Germanova,Daniele Dondossola,Tiziana Olivieri,Stefania Camagni,Andre Gorgen,Damiano Patrono,Matteo Cescon,Sarah Croome,Rebecca Panconesi,Rebecca Panconesi,Mauricio Flores Carvalho,Matteo Ravaioli,Juan Carlos Caicedo,George E. Loss,V. Lucidi,Gonzalo Sapisochin,Renato Romagnoli,Wayel Jassem,Michele Colledan,Luciano De Carlis,Giorgio Rossi,Fabrizio Di Benedetto,Charles Miller,Bart van Hoek,Magdy Attia,Peter Lodge,Roberto Hernandez-Alejandro,Olivier Detry,Cristiano Quintini,Gabriel C. Oniscu,Constantino Fondevila,Massimo Malagó,Jacques Pirenne,Jan Nm Ijzermans,Robert J. Porte,Philipp Dutkowski,C. Burcin Taner,Nigel Heaton,Pierre-Alain Clavien,Wojciech G. Polak,Paolo Muiesan,Paolo Muiesan,Paolo Muiesan,Ian P.J. Alwayn,Aad P. van der Berg,Margherita Carbonaro,Marco P. A. W. Claasen,Marco P. A. W. Claasen,Amna Daud,Vincent E de Meijer,Herold J. Metselaar,Diethard Monbaliu,Maite Paolucci,Sofie Vets,Erin Winter +80 more
TL;DR: In this paper, the best possible outcomes after liver transplantation of grafts donated after circulatory death (DCD) were defined using the concept of benchmarking, and the following benchmark cut-offs for the most relevant outcome parameters were developed: ICU and hospital stay: ≤3 and ≤16 days; primary non function: ≤2.5%; renal replacement therapy: ≤9.6%; ischemic cholangiopathy: ≤16.4%.
77
Hypothermic Oxygenated Liver Perfusion (HOPE) Prevents Tumor Recurrence in Liver Transplantation From Donation After Circulatory Death.
Matteo Mueller,Marit Kalisvaart,Marit Kalisvaart,Joanne O'Rourke,Shishir Shetty,Shishir Shetty,Alessandro Parente,Xavier Muller,John Isaac,Beat Muellhaupt,Paolo Muiesan,Tahir Shah,Pierre-Alain Clavien,Andrea Schlegel,Andrea Schlegel,Andrea Schlegel,Philipp Dutkowski +16 more
TL;DR: It is suggested that a simple machine liver perfusion approach appears advantageous to protect from HCC recurrence after liver transplantation, despite extended tumor criteria.